Effects of simvastatin administration in an experimental model of cancer cachexia
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro studyCarcinogenesis, 2001
- Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?Trends in Molecular Medicine, 2001
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Cancer cachexia: from experimental models to patient managementCurrent Opinion in Clinical Nutrition and Metabolic Care, 2000
- Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience, 1999
- Induction of Apoptosis and Necrosis in Human Neuroblastoma Cells by Cholesterol OxidesAnnals of the New York Academy of Sciences, 1999
- The role of cytokines in cancer cachexiaMedicinal Research Reviews, 1999
- Cracking the riddle of cancer anorexiaNutrition, 1996
- Review: Abnormal Substrate Metabolism and Nutritional Strategies in Cancer ManagementJournal of Parenteral and Enteral Nutrition, 1991
- Metabolic Approaches to Cancer CachexiaAnnual Review of Nutrition, 1982